Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioRestorative Therapies Inc (OTCQB:BRTX)

Delayed Data
As of Jan 18
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Contact Information

BioRestorative Therapies, Inc.
40 Marcus Drive
Melville New York 11747
P:(631) 760-8100
Investor Relations:



Individual stakeholders13.37%
Mutual fund holders--
Other institutional--

Top Executives

Mark WeinrebChairman, President, CEO, CFO & CAO
Mandy D. ClydeSecretary & Vice President-Operations
Francisco J. SilvaVice President-Research & Development
Robert PaccasassiVice President-Quality & Compliance
Edward L. FieldPresident-DISC Division